GALERA THERAPEUTICS, INC. (GRTX) Social Stream
GALERA THERAPEUTICS INC (GRTX) Price Targets From Analysts
Use the tables below to see what analysts covering GALERA THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-12 | 3 | $2 | $2 | $2 | $0.211 | 847.87% |
| 2021-12-14 | 3 | $2 | $2 | $2 | $0.211 | 847.87% |
| 2021-12-15 | 3 | $15 | $4 | $9.666 | $0.211 | 4481.04% |
| 2022-05-19 | 4 | $20 | $4 | $12.25 | $0.211 | 5705.69% |
| 2022-12-13 | 4 | $20 | $2 | $10.666 | $0.211 | 4954.98% |
| 2023-02-15 | 2 | $10 | $2 | $6 | $0.211 | 2743.6% |
| 2023-02-16 | 2 | $10 | $7 | $8.5 | $0.211 | 3928.44% |
| 2023-03-10 | 3 | $10 | $6 | $7.666 | $0.211 | 3533.18% |
| 2023-07-17 | 3 | $7 | $6 | $6.333 | $0.211 | 2901.42% |
| 2023-08-10 | 3 | $7 | $0.5 | $4.5 | $0.211 | 2032.7% |
| 2023-08-11 | 4 | $6 | $0.5 | $2.333 | $0.211 | 1005.69% |
| 2023-08-16 | 4 | $0.5 | $0.3 | $0.433 | $0.211 | 105.21% |
| 2023-08-29 | 2 | $0.5 | $0.25 | $0.375 | $0.211 | 77.73% |
| NA | 3 | $NA | $NA | $NA | $0.211 | NA% |
The Trend in the Analyst Price Target
Over the past 39 months, GRTX's average price target has gone down $18.88.
GRTX reports an average of 185.61% for its upside potential over the past 31 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-26 | 2 | 10.00 | 2.00 | 6.000 | 2.060 | 191.26% |
| 2023-08-10 | 3 | 7.00 | 0.50 | 4.500 | 0.360 | 1150% |
| 2023-08-16 | 4 | 0.50 | 0.30 | 0.433 | 0.251 | 72.51% |
| 2023-08-29 | 4 | 0.50 | 0.25 | 0.375 | 0.209 | 79.43% |
| 2023-08-29 | 4 | 0.25 | 0.25 | 0.250 | 0.209 | 19.62% |
GRTX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 3.33 | 0 | 0 | 2 | 0 | 0 | 3 |
The Trend in the Broker Recommendations
Over the past 42 months, GRTX's average broker recommendation rating worsened by 1.33.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how GALERA THERAPEUTICS INC fares relative to all US stocks, note that its average analyst price target is greater than 118.6% of that group.
- In the context of all US stocks, GALERA THERAPEUTICS INC's number of analysts covering the stock is greater than 175.81% of them.
- GRTX has a greater upside potential (average analyst target price relative to current price) than 1847.97% of all US stocks.
- To contextualize these metrics, consider that out of stocks in the small market cap category, GALERA THERAPEUTICS INC's variance in analysts' estimates is lower than -1265.7% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to GALERA THERAPEUTICS INC are PHAT, BCEL, and ENSC.
View All Top Stocks by Price Target
Is GRTX a Buy, Hold or Sell? See the POWR Ratings now!